Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gilead Sciences (NQ:GILD)

107.08 +1.21 (+1.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 26,497,838
Open 105.16
Bid (Size) 107.18 (1)
Ask (Size) 107.50 (4)
Prev. Close 105.87
Today's Range 104.92 - 107.42
52wk Range 62.07 - 119.96
Shares Outstanding 1,253,809,440
Dividend Yield 2.88%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed
UK pharma leaders warn excessive NHS levies threaten industry growth, urging the government to reform payments. The ABPI highlights declining UK R&D investment and falling global competitiveness. 
Via Benzinga
Q4 Earnings Review: Therapeutics Stocks Led by BioMarin Pharmaceutical (NASDAQ:BMRN)
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence

Performance

YTD
+16.5%
+16.5%
1 Month
-0.5%
-0.5%
3 Month
+15.7%
+15.7%
6 Month
+27.6%
+27.6%
1 Year
+46.5%
+46.5%

More News

Read More
Which S&P500 stocks are gapping on Thursday?
Via Chartmill
The Analyst Verdict: Gilead Sciences In The Eyes Of 14 Experts
Via Benzinga
Gilead Stock Wobbles On Federal HIV Funding Cut Buzz, But Retail And Analysts Stay Unfazed
Via Stocktwits
Stay informed with the top movers within the S&P500 index on Wednesday.
Via Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
Via Chartmill
Which S&P500 stocks are gapping on Wednesday?
Via Chartmill
Gilead Dives As HHS Reportedly Mulls Cutting HIV Prevention Funding
Via Investor's Business Daily
Wednesday's pre-market session: top gainers and losers in the S&P500 index
Via Chartmill
Crypto Mixed Post Trump-Putin Call; Trump Eyes HIV Program Cuts, Gilead Dips; Nvidia's AI Lead Secure Through 2028, Says JPMorgan – Top Headlines While The U.S. Slept
Via Benzinga
Topics Artificial Intelligence Government
Exposures Artificial Intelligence Political
Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides
Via Benzinga
Topics Government
Exposures Political
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Unpacking the Latest Options Trading Trends in Gilead Sciences
Via Benzinga
Gilead Sciences - Leader In HIV Medicines
Via Talk Markets
Topics Stocks / Equities
Exposures COVID-19
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
Is Gilead Sciences Gaining or Losing Market Support?
Via Benzinga
GILEAD SCIENCES INC (NASDAQ:GILD) Exhibits Quality Stock Traits. Here's Why.
Via Chartmill
Gilead Presents New HIV Treatment And Cure Research Data
Via Benzinga
Gilead Presents New HIV Treatment and Cure Research Data at CROI 2025, Including an Investigational Long-Acting, Twice-Yearly Therapy Option
From Gilead Sciences, Inc.
Via Business Wire
First Clinical Data for Gilead’s Investigational Once-Yearly Lenacapavir for HIV Prevention Presented at CROI 2025 and Published in The Lancet
From Gilead Sciences, Inc.
Via Business Wire
These 3 Dividend Stocks Jumped 15% in a Month—More to Come?
Via MarketBeat
Gilead Sciences To Rally Around 11%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
Winners And Losers Of Q4: Myriad Genetics (NASDAQ:MYGN) Vs The Rest Of The Therapeutics Stocks
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence

Frequently Asked Questions

Is Gilead Sciences publicly traded?
Yes, Gilead Sciences is publicly traded.
What exchange does Gilead Sciences trade on?
Gilead Sciences trades on the Nasdaq Stock Market
What is the ticker symbol for Gilead Sciences?
The ticker symbol for Gilead Sciences is GILD on the Nasdaq Stock Market
What is the current price of Gilead Sciences?
The current price of Gilead Sciences is 107.08
When was Gilead Sciences last traded?
The last trade of Gilead Sciences was at 03/21/25 04:00 PM ET
What is the market capitalization of Gilead Sciences?
The market capitalization of Gilead Sciences is 134.26B
How many shares of Gilead Sciences are outstanding?
Gilead Sciences has 134B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback